Literature DB >> 15172978

Disappearance of the telomere dysfunction-induced stress response in fully senescent cells.

Christopher J Bakkenist1, Rachid Drissi, Jing Wu, Michael B Kastan, Jeffrey S Dome.   

Abstract

Replicative senescence is a natural barrier to cellular proliferation that is triggered by telomere erosion and dysfunction. Here, we demonstrate that ATM activation and H2AX-gamma nuclear focus formation are sensitive markers of telomere dysfunction in primary human fibroblasts. Whereas the activated form of ATM and H2AX-gamma foci were rarely observed in early-passage cells, they were readily detected in late-passage cells. The ectopic expression of telomerase in late-passage cells abrogated ATM activation and H2AX-gamma focus formation, suggesting that these stress responses were the consequence of telomere dysfunction. ATM activation was induced in quiescent fibroblasts by inhibition of TRF2 binding to telomeres, indicating that telomere uncapping is sufficient to initiate the telomere signaling response; breakage of chromosomes with telomeric associations is not required for this activation. Although ATM activation and H2AX-gamma foci were readily observed in late-passage cells, they disappeared once cells became fully senescent, indicating that constitutive signaling from dysfunctional telomeres is not required for the maintenance of senescence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172978     DOI: 10.1158/0008-5472.CAN-04-0453

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells.

Authors:  Rachid Drissi; Jing Wu; Yafang Hu; Carol Bockhold; Jeffrey S Dome
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

2.  ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Authors:  Remy Pedeux; Sagar Sengupta; Jiang Cheng Shen; Oleg N Demidov; Shin'ichi Saito; Hitoshi Onogi; Kensuke Kumamoto; Stephen Wincovitch; Susan H Garfield; Mary McMenamin; Makoto Nagashima; Steven R Grossman; Ettore Appella; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 3.  Senescence and life span.

Authors:  Peter J Hornsby
Journal:  Pflugers Arch       Date:  2009-09-08       Impact factor: 3.657

4.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

5.  The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.

Authors:  Yafang Hu; Daniel Bobb; Jianping He; D Ashley Hill; Jeffrey S Dome
Journal:  Cancer Biol Ther       Date:  2015-04-28       Impact factor: 4.742

6.  Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines.

Authors:  Yi Zhang; Lin Cai; Ren-Xiong Wei; Hao Hu; Wei Jin; Xiao-Bin Zhu
Journal:  Oncol Lett       Date:  2011-09-02       Impact factor: 2.967

7.  Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.

Authors:  Priyatham Gorjala; Ronald K Gary
Journal:  Biometals       Date:  2010-06-12       Impact factor: 2.949

Review 8.  H2AX: functional roles and potential applications.

Authors:  Jennifer S Dickey; Christophe E Redon; Asako J Nakamura; Brandon J Baird; Olga A Sedelnikova; William M Bonner
Journal:  Chromosoma       Date:  2009-08-26       Impact factor: 4.316

9.  Modification of the ATM/ATR directed DNA damage response state with aging and long after hepatocyte senescence induction in vivo.

Authors:  Suchismita Panda; Ayman Isbatan; Guy R Adami
Journal:  Mech Ageing Dev       Date:  2008-03-14       Impact factor: 5.432

10.  Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation.

Authors:  Michael D Rainey; Maura E Charlton; Robert V Stanton; Michael B Kastan
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.